Kerstin Wenzl

Also affiliated with WinnMed, Bristol-Myers Squibb (United States), Mayo Clinic in Arizona, Mayo Clinic in Florida, Predictive Science (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients”.

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients

Blood Cancer Journal(2020)10.1038/s41408-020-00382-3

N/A

0DataRank · unranked

31 citations

Kerstin Wenzl, Keenan T. Hartert, Michelle K. Manske, Vivekananda Sarangi, Matthew J. Maurer +10 more

Molecular classification and identification of an aggressive signature in low‐grade B‐cell lymphomas

Hematological Oncology(2023)10.1002/hon.3187

N/A

0DataRank · unranked

5 citations

Kerstin Wenzl, Keenan T. Hartert, Jordan E. Krull, Abigail R. Dropik, Joseph P. Novak +16 more

Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation

Nature Communications(2024)10.1038/s41467-024-50830-y

N/A

0DataRank · unranked

17 citations

Kerstin Wenzl, C. Chris Huang, María Ortiz, Chih-Chao Hsu, Matthew J. Maurer +23 more

Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL

Blood Cancer Journal(2024)10.1038/s41408-024-01080-0

N/A

0DataRank · unranked

12 citations

Matthew E. Stokes, Joseph P. Novak, Allison M. Bock, Sana Khan, Melissa A. Hopper +25 more

Molecular Features of Diffuse Large B‐Cell Lymphoma Associated With Primary Treatment Resistance

Hematological Oncology(2024)10.1002/hon.70006

N/A

0DataRank · unranked

2 citations

Kerstin Wenzl, Joseph P. Novak, Matthew E. Stokes, Melissa A. Hopper, Jordan E. Krull +17 more

Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101443

N/A

0DataRank · unranked

11 citations

Kerstin Wenzl, Melissa A. Hopper, Michelle K. Manske, Vivekananda Sarangi, Matthew J. Maurer +16 more

DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas

Blood Cancer Journal(2024)10.1038/s41408-024-01145-0

N/A

0DataRank · unranked

4 citations

Abigail R. Dropik, Janek S. Walker, Joseph P. Novak, M. Laverty, Michelle K. Manske +16 more

Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma

Blood Cancer Journal(2025)10.1038/s41408-025-01326-5

N/A

0DataRank · unranked

7 citations

Kerstin Wenzl, Joseph P. Novak, Matthew E. Stokes, Melissa A. Hopper, Abigail R. Dropik +17 more

Investigating polyclonal Follicular Lymphoma tumors to determine the inciting factors for lymphomagenesis 4549

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.2220

N/A

0DataRank · unranked

0 citations

Jordan E. Krull, Joe Novak, Abigail R. Dropik, Janek S. Walker, Kerstin Wenzl +8 more